Zelluna Valuation Multiples
Discover revenue and EBITDA valuation multiples for Zelluna.
Zelluna Overview
About Zelluna
Zelluna ASA is a clinical-stage biotechnology company developing novel immunotherapies against cancer and the development of T-Cell Receptor Natural Killer cell therapies for the treatment of solid cancers. The company's current pipeline consists of allogeneic TCR-NK R&D programs ZI-MA4-1, ZI-KL1-1, and ZI-PR-1 targeting well validated antigens expressed across a broad range of solid tumors.
Founded
2011
HQ
Employees
12
Website
Financials (FY)
EV
$62M
Valuation Multiples
Start free trial
Zelluna Financials
Zelluna reported last fiscal year revenue of - and negative EBITDA of ($14M).
In the same fiscal year, Zelluna generated ($14M) in EBITDA losses and had net loss of ($15M).
Zelluna P&L
In the most recent fiscal year, Zelluna reported revenue of - and EBITDA of ($14M).
Zelluna is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
Zelluna Stock Performance
Zelluna has current market cap of $67M, and enterprise value of $62M.
Zelluna's stock price is $2.23.
Zelluna has an EPS (earnings per share) of $-0.50.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $62M | $67M | -1.4% | - | - | - | $-0.50 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialZelluna Valuation Multiples
Zelluna trades at (4.3x) EV/EBITDA.
Zelluna Financial Valuation Multiples
As of August 14, 2026, Zelluna has market cap of $67M and EV of $62M.
Zelluna has a P/E ratio of (4.5x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Zelluna Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Zelluna Margins & Growth Rates
Zelluna Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Zelluna Operational KPIs
Zelluna's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.2M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Zelluna Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Zelluna competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Zelluna
| When was Zelluna founded? | Zelluna was founded in 2011. |
| Where is Zelluna headquartered? | Zelluna is headquartered in Norway. |
| How many employees does Zelluna have? | As of today, Zelluna has over 12 employees. |
| Is Zelluna publicly listed? | Yes, Zelluna is a public company listed on Oslo Børs. |
| What is the stock symbol of Zelluna? | Zelluna trades under ZLNA ticker. |
| When did Zelluna go public? | Zelluna went public in 2019. |
| Who are competitors of Zelluna? | Zelluna main competitors include |
| What is the current market cap of Zelluna? | Zelluna's current market cap is $67M. |
| Is Zelluna profitable? | No, Zelluna is not profitable. |
| How many companies Zelluna has acquired to date? | Zelluna hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Zelluna has invested to date? | Zelluna hasn't invested in any companies yet (or none have been disclosed publicly). |
Lists including Zelluna
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.